DE602004001857D1 - Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen - Google Patents

Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen

Info

Publication number
DE602004001857D1
DE602004001857D1 DE602004001857T DE602004001857T DE602004001857D1 DE 602004001857 D1 DE602004001857 D1 DE 602004001857D1 DE 602004001857 T DE602004001857 T DE 602004001857T DE 602004001857 T DE602004001857 T DE 602004001857T DE 602004001857 D1 DE602004001857 D1 DE 602004001857D1
Authority
DE
Germany
Prior art keywords
sup
thienopyrimidindiones
modulation
autoimmune diseases
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004001857T
Other languages
English (en)
Other versions
DE602004001857T2 (de
Inventor
David Guile
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE602004001857D1 publication Critical patent/DE602004001857D1/de
Application granted granted Critical
Publication of DE602004001857T2 publication Critical patent/DE602004001857T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE602004001857T 2003-01-17 2004-01-15 Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen Expired - Lifetime DE602004001857T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0300119A SE0300119D0 (sv) 2003-01-17 2003-01-17 Novel compounds
SE0300119 2003-01-17
PCT/SE2004/000052 WO2004065394A1 (en) 2003-01-17 2004-01-15 Thienopyrimidinediones and their use in the modulation of autoimmune disease

Publications (2)

Publication Number Publication Date
DE602004001857D1 true DE602004001857D1 (de) 2006-09-21
DE602004001857T2 DE602004001857T2 (de) 2007-05-24

Family

ID=20290154

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004001857T Expired - Lifetime DE602004001857T2 (de) 2003-01-17 2004-01-15 Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen

Country Status (24)

Country Link
US (2) US7384951B2 (de)
EP (1) EP1587812B1 (de)
JP (1) JP4519121B2 (de)
KR (2) KR20110125256A (de)
CN (1) CN100334093C (de)
AT (1) ATE335748T1 (de)
AU (1) AU2004206012B2 (de)
BR (1) BRPI0406801B8 (de)
CA (1) CA2512441C (de)
DE (1) DE602004001857T2 (de)
EG (1) EG25613A (de)
ES (1) ES2270337T3 (de)
HK (1) HK1081959A1 (de)
IL (1) IL169370A (de)
IS (1) IS2376B (de)
MX (1) MXPA05007496A (de)
NO (1) NO333702B1 (de)
NZ (1) NZ541217A (de)
PL (1) PL214682B1 (de)
RU (1) RU2331647C2 (de)
SE (1) SE0300119D0 (de)
UA (1) UA81788C2 (de)
WO (1) WO2004065394A1 (de)
ZA (1) ZA200505364B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117583D0 (en) * 2001-07-19 2001-09-12 Astrazeneca Ab Novel compounds
GB0118479D0 (en) * 2001-07-28 2001-09-19 Astrazeneca Ab Novel compounds
SE0300120D0 (sv) 2003-01-17 2003-01-17 Astrazeneca Ab Novel compounds
US7393854B2 (en) * 2003-01-17 2008-07-01 Astrazeneca Ab Thienopyrimidinedinones and their use in modulation of autoimmune disease
ES2527118T3 (es) 2003-12-19 2015-01-20 Plexxikon Inc. Compuestos y procedimientos de desarrollo de moduladores de Ret
US7498342B2 (en) 2004-06-17 2009-03-03 Plexxikon, Inc. Compounds modulating c-kit activity
BRPI0610066A2 (pt) 2005-05-17 2010-05-25 Plexxikon Inc compostos que modulam atividade de c-kit e c-fms e usos para estes
CN102603581B (zh) 2005-06-22 2015-06-24 普莱希科公司 作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
PE20081581A1 (es) 2006-12-21 2008-11-12 Plexxikon Inc COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
WO2008080001A2 (en) 2006-12-21 2008-07-03 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
WO2008079909A1 (en) 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
GB0713479D0 (en) * 2007-07-11 2007-08-22 Syngenta Participations Ag Substituted aromatic heterocyclic compounds as fungicides
BRPI0814423B1 (pt) 2007-07-17 2022-04-19 Plexxikon, Inc Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos
WO2010089580A1 (en) 2009-02-06 2010-08-12 Astrazeneca Ab Use of a mct1 inhibitor in the treatment of cancers expressing mct1 over mct4
PL2411395T3 (pl) * 2009-03-23 2013-10-31 Glenmark Pharmaceuticals Sa Pochodne furopirymidynodionu jako modulatory TRPA1
PT2411397E (pt) * 2009-03-23 2013-06-06 Glenmark Pharmaceuticals Sa Derivados de isotiazolo-pirimidinadiona como moduladores de trpa1
CR20170089A (es) 2009-04-03 2017-07-17 Plexxikon Inc Composiciones del acido propano-1--sulfonico {3-[5-(4-cloro-fenil)-1h-pirrolo [2,3-b] piridina-3-carbonil] -2,4-difluoro-fenil}-amida y el uso de las mismas
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
WO2011057022A1 (en) 2009-11-06 2011-05-12 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
RS58455B1 (sr) 2011-02-07 2019-04-30 Plexxikon Inc Jedinjenja i postupci za modulaciju kinaze, i indikacije za njih
AR085279A1 (es) 2011-02-21 2013-09-18 Plexxikon Inc Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
EP2804852A2 (de) 2012-01-20 2014-11-26 Regents Of The University Of Minnesota Therapeutische verbindungen
WO2013112881A1 (en) 2012-01-27 2013-08-01 Thomas Jefferson University Mct protein inhibitor-related prognostic and therapeutic methods
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
EP2986290A4 (de) 2013-04-19 2017-01-04 Thomas Jefferson University Caveolin-1-verwandte verfahren zur behandlung von glioblastom mit temozolomid
PT3060562T (pt) * 2013-10-21 2021-09-02 Genosco Compostos de pirimidina substituídos e sua utilização como inibidores da syk
WO2016118825A1 (en) 2015-01-22 2016-07-28 The Scripps Research Institute Heterocyclic inhibitors of monocarboxylate transporters
UY36586A (es) * 2015-03-26 2016-10-31 Bayer Pharma AG Heterociclilmetiltienouracilos y uso de los mismos
KR101712838B1 (ko) * 2016-03-17 2017-03-07 주식회사 골프존 가상 골프 시뮬레이션 장치, 가상 골프를 위한 영상 구현 방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록 매체
KR101712836B1 (ko) * 2016-03-17 2017-03-22 주식회사 골프존 가상 골프 시뮬레이션 장치, 가상 골프를 위한 영상 구현 방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록 매체
KR101730536B1 (ko) * 2016-03-17 2017-05-02 주식회사 골프존 스크린 골프 시스템에서 구현되는 컨텐츠 전송 서비스 방법, 컨텐츠 전송 서비스를 위한 모바일 단말기의 제어방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록매체
TWI823932B (zh) * 2018-05-11 2023-12-01 中國大陸商迪哲（江蘇）醫藥有限公司 ***并嘧啶化合物及其在治療癌症中之用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US738495A (en) * 1902-12-26 1903-09-08 William E Sherwood Thill-coupling.
WO1999029695A1 (en) 1997-12-05 1999-06-17 Astrazeneca Uk Limited Novel compounds
SE9702001D0 (sv) 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds
US6469014B1 (en) * 1997-05-28 2002-10-22 Astrazeneca Ab Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy
US6232320B1 (en) 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
WO2000012514A1 (en) * 1998-08-28 2000-03-09 Astrazeneca Ab Novel compounds
EP1280806B1 (de) * 2000-05-04 2004-08-04 AstraZeneca AB THIENO[2,3-d]PYRIMIDINDIONE UND IHRE VERWENDUNG ALS PHARMAZEUTISCHE MITTEL
GB0117583D0 (en) * 2001-07-19 2001-09-12 Astrazeneca Ab Novel compounds
GB0118479D0 (en) * 2001-07-28 2001-09-19 Astrazeneca Ab Novel compounds
US7393854B2 (en) 2003-01-17 2008-07-01 Astrazeneca Ab Thienopyrimidinedinones and their use in modulation of autoimmune disease
SE0300120D0 (sv) 2003-01-17 2003-01-17 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
US20080214579A1 (en) 2008-09-04
BRPI0406801B8 (pt) 2021-05-25
HK1081959A1 (en) 2006-05-26
ATE335748T1 (de) 2006-09-15
CA2512441A1 (en) 2004-08-05
PL378222A1 (pl) 2006-03-20
NO20053826L (no) 2005-10-17
IS7965A (is) 2005-07-29
RU2331647C2 (ru) 2008-08-20
KR101107486B1 (ko) 2012-01-19
PL214682B1 (pl) 2013-09-30
AU2004206012B2 (en) 2007-06-14
EP1587812B1 (de) 2006-08-09
BRPI0406801A (pt) 2006-01-17
IS2376B (is) 2008-07-15
US7384951B2 (en) 2008-06-10
US20060052400A1 (en) 2006-03-09
IL169370A (en) 2011-05-31
DE602004001857T2 (de) 2007-05-24
KR20110125256A (ko) 2011-11-18
MXPA05007496A (es) 2005-09-21
IL169370A0 (en) 2007-07-04
SE0300119D0 (sv) 2003-01-17
NO20053826D0 (no) 2005-08-15
UA81788C2 (uk) 2008-02-11
AU2004206012A1 (en) 2004-08-05
JP2006516974A (ja) 2006-07-13
KR20050092760A (ko) 2005-09-22
ZA200505364B (en) 2006-09-27
WO2004065394A1 (en) 2004-08-05
RU2005121494A (ru) 2006-02-10
CN1761672A (zh) 2006-04-19
NZ541217A (en) 2008-05-30
BRPI0406801B1 (pt) 2018-04-03
EP1587812A1 (de) 2005-10-26
JP4519121B2 (ja) 2010-08-04
ES2270337T3 (es) 2007-04-01
CN100334093C (zh) 2007-08-29
NO333702B1 (no) 2013-08-26
EG25613A (en) 2012-03-22
CA2512441C (en) 2012-01-03

Similar Documents

Publication Publication Date Title
DE602004001857D1 (de) Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen
HK1048990A1 (en) Novel compounds.
IS6658A (is) Ný efnasambönd
SE0302139D0 (sv) Novel compounds
ATE433447T1 (de) Pyrimiidinverbindungen
SE9902987D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
SE0200920D0 (sv) Novel compounds
SE0300480D0 (sv) Novel compounds
SE0202133D0 (sv) Novel compounds
AU2003228770A8 (en) Substituted pyrazolopyrimidines
EA200401526A1 (ru) Новые соединения и их применение
TW200604197A (en) New compounds
SE0101038D0 (sv) Novel compounds
EA200701856A1 (ru) Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении
GB0120461D0 (en) Novel compounds
SE0303280D0 (sv) Novel compounds
IL172538A0 (en) Depsipeptide compounds, pharmaceutical compositions containing the same and processes for the preparation thereof
SE0401763D0 (sv) Compounds
ATE497967T1 (de) Interzelluläre kommunikation erleichternden verbindungen und deren medizinischen verwendungen
EA200600992A1 (ru) Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение
SE9902551D0 (sv) Novel compounds
SE0303090D0 (sv) Novel compounds
SE0302755D0 (sv) Novel compounds
SE0202692D0 (sv) Compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition